Praziquantel
Discovery and Development of an Anthelmintic Drug
Contributor(s)
Spangenberg, Thomas (editor)
Language
EnglishAbstract
This open-access book provides a comprehensive reference on the discovery and development of praziquantel. It presents the full research and development (R&D) journey of this essential anthelmintic drug, combining foundational science with practical insights. The book covers a wide range of topics, including a brief history of pharmaceutical industry, unmet medical needs, parasitic flatworm biology, and strategies for schistosomiasis control and elimination. Both human and animal health applications are addressed. Additional chapters explore chemical and manufacturing aspects, drug targets, biomarkers, toxicology, clinical efficacy, regulatory pathways, and Intellectual Property considerations. Rich illustrations, expert commentary, and clear summaries enhance the educational value of the text. Designed for students, academics, and industry professionals alike, this volume serves as a valuable addition to any scientific library. It also supports the United Nations Sustainable Development Goal 3 (Good Health and Well-being) by contributing to the global fight against schistosomiasis and other Neglected Tropical Diseases.
Keywords
Praziquantel; Arpraziquantel; Anti-infective drug; R&D; research and development; Schistosomiasis; Trematode; Trematode control; Anthelmintic drug; Drug discovery; Open Access; Bilharzia; Neglected Tropical Disease; NTD; SDG3; Good Health and Well-beingDOI
10.1007/978-3-031-97397-0ISBN
9783031973970, 9783031973970, 9783031973963Publisher
Springer NaturePublisher website
https://www.springernature.com/gp/products/booksPublication date and place
Cham, 2026Imprint
SpringerSeries
Biomedical and Life Sciences; Biomedical and Life Sciences (R0),Classification
Microbiology (non-medical)
Pharmacology


Download
Web Shop